Fas-associated death-domain protein inhibits TNF-α mediated NF-κB activation in cardiomyocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 5 58-5, 2005, Pages

  Chao, Wei ^a   Shen, Yan ^a   Li, Ling ^a   Zhao, Huailong ^a   Meiler, Steffen E ^b   Cook, Stuart A ^a   Rosenzweig, Anthony ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cardiac; Inflammation; Nuclear factor B; Signal transduction; Tumor necrosis factor

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CASPASE 8; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GREEN FLUORESCENT PROTEIN; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL TYPE; CONTROLLED STUDY; CYTOSOL; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE TRANSFER; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PULMONARY ARTERY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANIMALS, NEWBORN; BIOTRANSFORMATION; CARRIER PROTEINS; CELL LINE; CELL NUCLEUS; CYTOSOL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; I-KAPPA B PROTEINS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOCYTES, CARDIAC; NF-KAPPA B; NUCLEAR PROTEINS; PHOSPHORYLATION; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27144441737     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01216.2004     Document Type: Article

References (37)

1. Bannerman DD, Tupper JC, Kelly JD, Winn RK, and Harlan JM. The Fas-associated death domain protein suppresses activation of NF-kappa B by LPS and IL-1 beta. J Clin Invest 109: 419-425, 2002.
2. Chao W, Shen Y, Li L, and Rosenzweig A. Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis. J Biol Chem 277: 31639-31645, 2002.
3. Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, and Hood L. Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 19: 4451-4460, 2000.
4. Chinnaiyan AM, O'Rourke K, Tewari M, and Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 8145: 505-512, 1995.
5. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, and Dixit VM. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271: 4961-4965, 1996.
6. Collins T and Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107: 255-264, 2001.
7. Cook SA, Matsui T, Li L, and Rosenzweig A. Transcriptional effects of chronic Akt activation in the heart. J Biol Chem 277: 22528-22533, 2002.
8. Cook SA, Novikov MS, Ahn Y, Matsui T, and Rosenzweig A. A20 is dynamically regulated in the heart and inhibits the hypertrophic response. Circulation 108: 664-667, 2003.
9. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, and Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388: 548-554, 1997.
10. Erl W, Hansson GK, de Martin R, Draude G, Weber KS, and Weber C. Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res 84: 668-677, 1999.
11. Force T, Haq S, Kilter H, and Michael A. Apoptosis signal-regulating kinase/nuclear factor-kappaB: a novel signaling pathway regulates cardiomyocyte hypertrophy. Circulation 105: 402-404, 2002.
12. Gerszten RE, Friedrich EB, Matsui T, Hung RR, Li L, Force T, and Rosenzweig A. Role of phosphoinositide 3-kinase in monocyte recruitment under flow conditions. J Biol Chem 276: 26846-26851, 2001.
13. Ghosh S and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl: S81-S96, 2002.
14. Gurevitch J, Frolkis I, Yuhas Y, Paz Y, Matsa M, Mohr R, and Yakirevich V. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coli Cardio 28: 247-252, 1996.
15. Hu WH, Johnson H, and Shu HB. Activation of NF-kappaB by FADD, Casper, and caspase-8. J Biol Chem 275: 10838-10844, 2000.
16. Karin M and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kappaB activity. Annu Rev Immunol 18: 621-663, 2000.
17. Kataoka T, Budd RC, Holler N, Thome M, Martinen F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, and Tschopp J. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 10: 640-648, 2000.
18. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, and Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 81: 627-635, 1997.
19. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, and Rose NR. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J Immunol 151: 1682-1690, 1993.
20. Lee P, Sata M, Lefer DJ, Factor SM, Walsh K, and Kitsis RN. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol 284: H456-H463, 2003.
21. Matsui T, Li L, del Monte F, Fukui Y, Franke TF, Hajjar RJ, and Rosenzweig A. Adenoviral gene transfer of activated phosphatidylinositol 3′ -kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 100: 2373-2379, 1999.
22. Meiler SE, Hung RR, Gerszten RE, Gianetti J, Li L, Matsui T, Gimbrone MA Jr, and Rosenzweig A. Endothelial IKK beta signaling is required for monocyte adhesion under laminar flow conditions. J Mol Cell Cardiol 34: 349-359, 2002.
23. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, and Rao A. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278: 860-866, 1997.
24. Mustapha S, Kirshner A, De Moissac D, and Kirshenbaum LA. A direct requirement of nuclear factor-kappa B for suppression of apoptosis in ventricular myocytes. Am J Physiol Heart Circ Physiol 279: H939-H945, 2000.
25. Pfaffi MW, Georgieva TM, Georgiev IP, Ontsouka E, Hageleit M, and Blum JW. Real-time RT-PCR quantification of insulin-like growth factor (IGF)-1, IGF-1 receptor, IGF-2, IGF-2 receptor, insulin receptor, growth hormone receptor, IGF-binding proteins 1, 2, and 3 in the bovine species. Domest Anim Endocrinol 22: 91-102, 2002.
26. Pimentel-Muinos FX and Seed B. Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. Immunity 11: 783-793, 1999.
27. Schaub FJ, Han DK, Liles WC, Adams LD, Coats SA, Ramachandran RK, Seifert RA, Schwartz SM, and Bowen-Pope DF. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med 6: 790-796, 2000.
28. Stehlik C, de Martin R, Binder BR, and Lipp J. Cytokine induced expression of porcine inhibitor of apoptosis protein (iap) family member is regulated by NF-kappa B. Biochem Biophys Res Commun 243: 827-832, 1998.
29. Takata M, Filippov G, Liu H, Ichinose F, Janssens S, Bloch DB, and Bloch KD. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms. Am J Physiol Lung Cell Mol Physiol 280: L272-L278, 2001.
30. Takeda K, Kaisho T, and Akira S. Toll-like receptors. Annu Rev Immunol 21: 335-376, 2003.
31. Ting AT, Pimentel-Muinos FX, and Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. Embo J 15: 6189-6196, 1996.
32. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, and Mann DL. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93: 704-711, 1996.
33. Valen G, Yan ZQ, and Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38: 307-314, 2001.
34. Wajant H, Haas E, Schwenzer R, Muhlenbeck F, Kreuz S, Schubert G, Grell M, Smith C, and Scheurich P. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). J Biol Chem 275: 24357-24366, 2000.
35. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, and Baldwin AS Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683, 1998.
36. Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV, and Mak TW. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279: 1954-1958, 1998.
37. Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, and Schreiber RD. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 291: 2162-2165, 2001.